Clinical Trial Update: A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of NKT3447 in adults with advanced or metastatic solid tumors has been terminated. The study encompassed indications including ovarian cancer, end…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Gastric Cancer
• Ovarian Cancer
• Small Cell Lung Cancer

Drugs mentioned

• NKT3447

Snippet

Sponsor: NiKang Therapeutics, Inc. | Conditions: Solid Tumor, Solid Tumor, Adult | Phase 1 | Status: TERMINATED